688426 康为世纪
已收盘 04-29 15:00:00
资讯
新帖
简况
图解康为世纪一季报：第一季度单季净利润同比增长32.50%
证券之星 · 04-29 18:22
图解康为世纪一季报：第一季度单季净利润同比增长32.50%
康为世纪(688426)3月31日股东户数0.44万户，较上期增加14.98%
证券之星 · 04-29 17:43
康为世纪(688426)3月31日股东户数0.44万户，较上期增加14.98%
康为世纪(688426.SH)发布一季度业绩，归母净亏损1535万元
智通财经 · 04-29 15:58
康为世纪(688426.SH)发布一季度业绩，归母净亏损1535万元
康为世纪（688426）7380万股限售股将于4月27日解禁，占总股本65.6%
证券之星 · 04-27 08:02
康为世纪（688426）7380万股限售股将于4月27日解禁，占总股本65.6%
康为世纪(688426)3月31日股东户数0.44万户，较上期增加14.98%
证券之星 · 04-24
康为世纪(688426)3月31日股东户数0.44万户，较上期增加14.98%
图解康为世纪年报：第四季度单季净利润同比增长49.23%
证券之星 · 04-24
图解康为世纪年报：第四季度单季净利润同比增长49.23%
每周股票复盘：康为世纪（688426）65.6%限售股将上市流通
证券之星 · 04-19
每周股票复盘：康为世纪（688426）65.6%限售股将上市流通
康为世纪（688426）披露首次公开发行部分限售股上市流通公告，4月17日股价下跌1.27%
证券之星 · 04-17
康为世纪（688426）披露首次公开发行部分限售股上市流通公告，4月17日股价下跌1.27%
3月23日康为世纪跌7.78%，融通价值成长混合A基金重仓该股
证券之星 · 03-23
3月23日康为世纪跌7.78%，融通价值成长混合A基金重仓该股
每周股票复盘：康为世纪（688426）九项呼吸道病原体检测试剂获三类医疗器械注册证
证券之星 · 03-08
每周股票复盘：康为世纪（688426）九项呼吸道病原体检测试剂获三类医疗器械注册证
康为世纪(688426.SH)：九项呼吸道病原体核酸检测试剂盒(荧光PCR法)获医疗器械注册证
智通财经 · 03-04
康为世纪(688426.SH)：九项呼吸道病原体核酸检测试剂盒(荧光PCR法)获医疗器械注册证
3月3日康为世纪创60日新低，融通价值成长混合A基金重仓该股
证券之星 · 03-03
3月3日康为世纪创60日新低，融通价值成长混合A基金重仓该股
股市必读：康为世纪发布2025年度业绩快报，亏损1.033亿元
证券之星 · 03-02
股市必读：康为世纪发布2025年度业绩快报，亏损1.033亿元
每周股票复盘：康为世纪（688426）2025年净亏1.03亿同比收窄
证券之星 · 03-01
每周股票复盘：康为世纪（688426）2025年净亏1.03亿同比收窄
康为世纪（688426）披露更换持续督导保荐代表人公告，2月24日股价上涨3.45%
证券之星 · 02-24
康为世纪（688426）披露更换持续督导保荐代表人公告，2月24日股价上涨3.45%
每周股票复盘：康为世纪（688426）内审部负责人因退休离职
证券之星 · 02-08
每周股票复盘：康为世纪（688426）内审部负责人因退休离职
康为世纪(688426.SH)发预亏，预计2025年归母净亏损9144.1万元到1.12亿元
智通财经 · 01-29
康为世纪(688426.SH)发预亏，预计2025年归母净亏损9144.1万元到1.12亿元
康为世纪（688426）披露终止实施2024年限制性股票激励计划议案，1月28日股价下跌2.11%
证券之星 · 01-28
康为世纪（688426）披露终止实施2024年限制性股票激励计划议案，1月28日股价下跌2.11%
每周股票复盘：康为世纪（688426）拟终止2024年股权激励计划
证券之星 · 01-18
每周股票复盘：康为世纪（688426）拟终止2024年股权激励计划
康为世纪（688426）公司公告拟终止实施2024年限制性股票激励计划，1月14日股价上涨3.24%
证券之星 · 01-14
康为世纪（688426）公司公告拟终止实施2024年限制性股票激励计划，1月14日股价上涨3.24%
加载更多
公司概况
公司名称：
江苏康为世纪生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2022-10-25
主营业务：
江苏康为世纪生物科技股份有限公司的主营业务是分子检测底层核心技术的自主研发。公司的主要产品是分子检测原料酶、核酸保存试剂、核酸提取纯化试剂以及分子诊断试剂盒。
发行价格：
48.98
{"stockData":{"symbol":"688426","market":"SH","secType":"STK","nameCN":"康为世纪","latestPrice":20.4,"timestamp":1777446000000,"preClose":19.85,"halted":0,"volume":1368079,"delay":0,"changeRate":0.0277,"floatShares":112000000,"shares":112000000,"eps":-0.8892,"marketStatus":"已收盘","change":0.55,"latestTime":"04-29 15:00:00","open":19.86,"high":20.64,"low":19.74,"amount":27873300,"amplitude":0.0453,"askPrice":20.46,"askSize":12,"bidPrice":20.4,"bidSize":46,"shortable":0,"etf":0,"ttmEps":-0.8892,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777512600000},"marketStatusCode":5,"adr":0,"adjPreClose":19.85,"symbolType":"stock_kcb","openAndCloseTimeList":[[1777426200000,1777433400000],[1777438800000,1777446000000]],"highLimit":21.84,"lowLimit":17.87,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":112493716,"isCdr":false,"pbRate":1.7,"roa":"--","roe":"--","epsLYR":-0.977,"committee":-0.279693,"marketValue":2295000000,"turnoverRate":0.0122,"status":0,"afterMarket":{"amount":0,"volume":0,"close":20.4,"buyVolume":0,"sellVolume":0,"time":1777448037558,"indexStatus":"已收盘 04-29 15:30:00","preClose":19.85},"floatMarketCap":2289000000},"requestUrl":"/m/hq/s/688426","defaultTab":"news","newsList":[{"id":"2631949245","title":"图解康为世纪一季报：第一季度单季净利润同比增长32.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631949245","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631949245?lang=zh_cn&edition=full","pubTime":"2026-04-29 18:22","pubTimestamp":1777458153,"startTime":"0","endTime":"0","summary":"证券之星消息，康为世纪2026年一季报显示，一季度公司主营收入5899.73万元，同比上升37.19%；归母净利润-1535.2万元，同比上升32.5%；扣非净利润-2058.1万元，同比上升28.47%；负债率8.69%，投资收益172.56万元，财务费用54.74万元，毛利率47.18%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900058779.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631596517","title":"康为世纪(688426)3月31日股东户数0.44万户，较上期增加14.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631596517","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631596517?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:43","pubTimestamp":1777455834,"startTime":"0","endTime":"0","summary":"证券之星消息，近日康为世纪披露，截至2026年3月31日公司股东户数为4406.0户，较12月31日增加574.0户，增幅为14.98%。在医疗器械行业个股中，康为世纪股东户数低于行业平均水平，截至3月31日，医疗器械行业平均股东户数为2.2万户。从股价来看，2025年12月31日至2026年3月31日，康为世纪区间跌幅为15.95%，在此期间股东户数增加574.0户，增幅为14.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900055473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631562464","title":"康为世纪(688426.SH)发布一季度业绩，归母净亏损1535万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2631562464","media":"智通财经","labels":["dataReport"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631562464?lang=zh_cn&edition=full","pubTime":"2026-04-29 15:58","pubTimestamp":1777449521,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康为世纪(688426.SH)披露2026年第一季度报告，报告期公司实现营收5899.73万元，同比增长37.19%;归母净利润亏损1535万元;扣非净利润亏损2058万元。基本每股收益-0.14元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436113.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"康为世纪(688426.SH)发布一季度业绩，归母净亏损1535万元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630332484","title":"康为世纪（688426）7380万股限售股将于4月27日解禁，占总股本65.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630332484","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630332484?lang=zh_cn&edition=full","pubTime":"2026-04-27 08:02","pubTimestamp":1777248142,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，康为世纪于4月27日将有7380.0万股限售股份解禁，为公司追加承诺限售股份上市流通，占公司总股本65.6%。最近一年内，该股累计解禁43.42万股，占总股本的0.39%。本次解禁后，公司还有26.61万股限售股份，占总股本0.24%。康为世纪主营业务：分子检测底层核心技术的自主研发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700007358.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629814966","title":"康为世纪(688426)3月31日股东户数0.44万户，较上期增加14.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629814966","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629814966?lang=zh_cn&edition=full","pubTime":"2026-04-24 17:31","pubTimestamp":1777023087,"startTime":"0","endTime":"0","summary":"证券之星消息，近日康为世纪披露，截至2026年3月31日公司股东户数为4406.0户，较12月31日增加574.0户，增幅为14.98%。在医疗器械行业个股中，康为世纪股东户数低于行业平均水平，截至3月31日，医疗器械行业平均股东户数为2.18万户。从股价来看，2025年12月31日至2026年3月31日，康为世纪区间跌幅为15.95%，在此期间股东户数增加574.0户，增幅为14.98%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400052643.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629545158","title":"图解康为世纪年报：第四季度单季净利润同比增长49.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629545158","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629545158?lang=zh_cn&edition=full","pubTime":"2026-04-24 01:43","pubTimestamp":1776966192,"startTime":"0","endTime":"0","summary":"证券之星消息，康为世纪2025年年报显示，当年度公司主营收入1.94亿元，同比上升53.74%；归母净利润-1.07亿元，同比上升31.68%；扣非净利润-1.4亿元，同比上升22.61%；其中2025年第四季度，公司单季度主营收入5394.55万元，同比上升95.51%；单季度归母净利润-3125.01万元，同比上升49.23%；单季度扣非净利润-4582.6万元，同比上升35.43%；负债率9.25%，投资收益1376.94万元，财务费用53.13万元，毛利率45.41%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400004226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628775135","title":"每周股票复盘：康为世纪（688426）65.6%限售股将上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2628775135","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628775135?lang=zh_cn&edition=full","pubTime":"2026-04-19 03:30","pubTimestamp":1776540627,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，康为世纪报收于20.14元，较上周的20.16元下跌0.1%。本周，康为世纪4月16日盘中最高价报20.58元。4月13日盘中最低价报19.82元。康为世纪当前最新总市值22.66亿元，在医疗器械板块市值排名123/129，在两市A股市值排名5043/5198。上述股份锁定期为自公司股票上市之日起42个月，原因为触发延长承诺条件。本次上市流通后，相关股东剩余限售股数量为0。保荐人中信证券对本次限售股上市流通事项无异议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900001221.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628427294","title":"康为世纪（688426）披露首次公开发行部分限售股上市流通公告，4月17日股价下跌1.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628427294","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628427294?lang=zh_cn&edition=full","pubTime":"2026-04-17 17:39","pubTimestamp":1776418776,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，康为世纪报收于20.14元，较前一交易日下跌1.27%，最新总市值为22.66亿元。公司于2026年4月17日发布《首次公开发行部分限售股上市流通公告》。公告显示，江苏康为世纪生物科技股份有限公司首次公开发行部分限售股将于2026年4月27日上市流通，本次上市流通数量为73,800,000股，占公司总股本的65.6037%。上述股东均已履行相关股份锁定承诺，不存在资金占用情况，保荐机构对本次限售股上市流通无异议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700033679.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621884776","title":"3月23日康为世纪跌7.78%，融通价值成长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2621884776","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621884776?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:39","pubTimestamp":1774255187,"startTime":"0","endTime":"0","summary":"证券之星消息，3月23日康为世纪跌7.78%创60日新低，收盘报19.44元，换手率4.64%，成交量1.78万手，成交额3556.16万元。重仓康为世纪的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为融通基金的融通价值成长混合A。该公募基金现任基金经理为万民远。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300025374.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617663864","title":"每周股票复盘：康为世纪（688426）九项呼吸道病原体检测试剂获三类医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2617663864","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617663864?lang=zh_cn&edition=full","pubTime":"2026-03-08 02:37","pubTimestamp":1772908630,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，康为世纪报收于23.15元，较上周的25.13元下跌7.88%。本周，康为世纪3月2日盘中最高价报25.0元。3月4日盘中最低价报22.4元。康为世纪当前最新总市值26.04亿元，在医疗器械板块市值排名122/129，在两市A股市值排名4933/5190。该产品采用荧光PCR法和冻干技术，具备高通量、高灵敏度、稳定可靠、便于保存运输、操作便捷等特点。注册证有效期至2031年3月2日。本次获批有助于完善公司呼吸道疾病检测整体解决方案，提升市场竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800000837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK1574","159883","09996","688426","BK0239","09997","BK1222","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616538381","title":"康为世纪(688426.SH)：九项呼吸道病原体核酸检测试剂盒(荧光PCR法)获医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2616538381","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616538381?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:41","pubTimestamp":1772613708,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康为世纪 公告，公司全资子公司江苏健为诊断科技有限公司自主研发的九项呼吸道病原体核酸检测试剂盒收到国家药品监督管理局颁发的III类《医疗器械注册证》。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409939.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","688426","BK1574","09996","PCR","BK0239","BK1100","BK1222","BK1583","09997"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616317875","title":"3月3日康为世纪创60日新低，融通价值成长混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2616317875","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616317875?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:38","pubTimestamp":1772527101,"startTime":"0","endTime":"0","summary":"证券之星消息，3月3日康为世纪创60日新低，收盘报22.94元，当日跌3.12%，换手率3.39%，成交量1.3万手，成交额3048.89万元。重仓康为世纪的公募基金请见下表：根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为融通基金的融通价值成长混合A。融通价值成长混合A目前规模为1.03亿元，最新净值1.3035，较上一交易日下跌2.08%，近一年上涨27.33%。该公募基金现任基金经理为万民远。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300029071.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616876113","title":"股市必读：康为世纪发布2025年度业绩快报，亏损1.033亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616876113","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616876113?lang=zh_cn&edition=full","pubTime":"2026-03-02 03:06","pubTimestamp":1772391974,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，康为世纪报收于25.13元，上涨0.12%，换手率2.8%，成交量1.08万手，成交额2703.64万元。业绩披露要点业绩快报康为世纪近日即将发布2025年年报，根据2月27日发布的业绩快报，归属净利润亏损1.033亿元，同比增长34.3%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200001407.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616845516","title":"每周股票复盘：康为世纪（688426）2025年净亏1.03亿同比收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2616845516","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616845516?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:42","pubTimestamp":1772304132,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，康为世纪报收于25.13元，较上周的24.65元上涨1.95%。本周，康为世纪2月24日盘中最高价报25.75元。本周关注点业绩披露要点：康为世纪2025年归属净利润亏损1.033亿元，同比收窄34.3%。江苏康为世纪生物科技股份有限公司发布2025年度业绩快报，营业总收入为19,304.82万元，同比增长53.36%；营业利润为-10,479.00万元，利润总额为-10,732.07万元，归属于母公司所有者的净利润为-10,328.49万元，亏损较上年同期收窄。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000969.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613771058","title":"康为世纪（688426）披露更换持续督导保荐代表人公告，2月24日股价上涨3.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613771058","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613771058?lang=zh_cn&edition=full","pubTime":"2026-02-24 22:26","pubTimestamp":1771943177,"startTime":"0","endTime":"0","summary":"截至2026年2月24日收盘，康为世纪报收于25.5元，较前一交易日上涨3.45%，最新总市值为28.69亿元。近日，江苏康为世纪生物科技股份有限公司收到中信证券《关于更换持续督导保荐代表人的函》，因原保荐代表人杨凌先生工作变动，不再担任公司持续督导保荐代表人。本次更换后，公司持续督导保荐代表人为王伟先生和姜浩先生。公司董事会对杨凌先生在持续督导期间的贡献表示感谢。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400043993.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609526222","title":"每周股票复盘：康为世纪（688426）内审部负责人因退休离职","url":"https://stock-news.laohu8.com/highlight/detail?id=2609526222","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609526222?lang=zh_cn&edition=full","pubTime":"2026-02-08 03:20","pubTimestamp":1770492024,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘，康为世纪报收于25.9元，较上周的26.63元下跌2.74%。本周，康为世纪2月2日盘中最高价报27.92元。公司公告汇总江苏康为世纪生物科技股份有限公司内审部负责人汤玉峰先生因退休原因提交书面离职报告，辞职后不再担任公司任何职务。该离职报告自送达董事会之日起生效，不会对公司生产经营造成影响，公司将按规定聘任新的内部审计负责人。公司董事会对汤玉峰先生在任期间的贡献表示感谢。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800001225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607970211","title":"康为世纪(688426.SH)发预亏，预计2025年归母净亏损9144.1万元到1.12亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607970211","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607970211?lang=zh_cn&edition=full","pubTime":"2026-01-29 17:08","pubTimestamp":1769677697,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康为世纪(688426.SH)发布公告，公司预计2025年年度实现归属于母公司所有者的净利润与上年同期相比将实现减亏，归属于母公司所有者的净利润-1.12亿元到-9144.1万元，同比减亏28.91%到41.83%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399177.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"康为世纪(688426.SH)发预亏，预计2025年归母净亏损9144.1万元到1.12亿元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606710239","title":"康为世纪（688426）披露终止实施2024年限制性股票激励计划议案，1月28日股价下跌2.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606710239","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606710239?lang=zh_cn&edition=full","pubTime":"2026-01-28 22:58","pubTimestamp":1769612293,"startTime":"0","endTime":"0","summary":"截至2026年1月28日收盘，康为世纪报收于27.4元，较前一交易日下跌2.11%，最新总市值为30.82亿元。该股当日开盘28.28元，最高28.28元，最低27.22元，成交额达2388.41万元，换手率为2.26%。近日，康为世纪发布2026年第一次临时股东会决议公告。公告显示，公司于2026年1月28日召开2026年第一次临时股东会，审议通过《关于终止实施2024年限制性股票激励计划的议案》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800043375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604925258","title":"每周股票复盘：康为世纪（688426）拟终止2024年股权激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2604925258","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604925258?lang=zh_cn&edition=full","pubTime":"2026-01-18 04:24","pubTimestamp":1768681449,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，康为世纪报收于27.01元，较上周的26.17元上涨3.21%。本周，康为世纪1月14日盘中最高价报29.14元。本周关注点公司公告汇总：康为世纪拟终止2024年限制性股票激励计划，取消未归属股票1,590,600股。股本股东变化：董事及高管庄志华、戚玉柏、殷剑峰拟合计减持不超过43,250股。庄志华拟减持不超过21,958股，戚玉柏拟减持不超过11,311股，殷剑峰拟减持不超过9,981股，减持期间为2026年2月5日至2026年5月5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800001331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688426","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603961251","title":"康为世纪（688426）公司公告拟终止实施2024年限制性股票激励计划，1月14日股价上涨3.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603961251","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603961251?lang=zh_cn&edition=full","pubTime":"2026-01-14 22:34","pubTimestamp":1768401251,"startTime":"0","endTime":"0","summary":"截至2026年1月14日收盘，康为世纪报收于27.44元，较前一交易日上涨3.24%，最新总市值为30.87亿元。近日，江苏康为世纪生物科技股份有限公司发布《2026年第一次临时股东会会议资料》公告，披露公司拟终止实施2024年限制性股票激励计划。公司决定取消第二个、第三个归属期尚未归属的第二类限制性股票合计1,590,600股，并作废失效。公司承诺自股东大会审议通过之日起3个月内不再审议和披露股权激励计划。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400041498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688426"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777479564966,"stockEarnings":[{"period":"1week","weight":-0.0055},{"period":"1month","weight":-0.0183},{"period":"3month","weight":-0.2755},{"period":"6month","weight":-0.2816},{"period":"1year","weight":0.1343},{"period":"ytd","weight":-0.167}],"compareEarnings":[{"period":"1week","weight":-0.0016},{"period":"1month","weight":0.0421},{"period":"3month","weight":-0.0175},{"period":"6month","weight":0.023},{"period":"1year","weight":0.2403},{"period":"ytd","weight":0.0277}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏康为世纪生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"4406人(较上一季度增加14.98%)","perCapita":"25471股","listingDate":"2022-10-25","address":"江苏省泰州市海陵区医药高新区泽兰路18号","registeredCapital":"11249万元","survey":" 江苏康为世纪生物科技股份有限公司的主营业务是分子检测底层核心技术的自主研发。公司的主要产品是分子检测原料酶、核酸保存试剂、核酸提取纯化试剂以及分子诊断试剂盒。","listedPrice":48.98},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康为世纪(688426)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康为世纪(688426)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康为世纪,688426,康为世纪股票,康为世纪股票老虎,康为世纪股票老虎国际,康为世纪行情,康为世纪股票行情,康为世纪股价,康为世纪股市,康为世纪股票价格,康为世纪股票交易,康为世纪股票购买,康为世纪股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康为世纪(688426)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康为世纪(688426)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}